Envoy Medical, Inc. COCH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.98M | -4.35M | -6.59M | -6.48M | -5.69M |
| Total Depreciation and Amortization | 74.00K | 73.00K | 80.00K | 76.00K | 85.00K |
| Total Amortization of Deferred Charges | 236.00K | 227.00K | 226.00K | 245.00K | 246.00K |
| Total Other Non-Cash Items | 895.00K | -1.25M | 517.00K | 1.07M | 822.00K |
| Change in Net Operating Assets | -679.00K | -758.00K | 78.00K | 762.00K | 77.00K |
| Cash from Operations | -5.46M | -6.06M | -5.69M | -4.33M | -4.46M |
| Capital Expenditure | -6.00K | -- | -172.00K | 0.00 | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.00K | -- | -172.00K | 0.00 | -1.00K |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 5.00M |
| Total Debt Repaid | -213.00K | -208.00K | -191.00K | -267.00K | -236.00K |
| Issuance of Common Stock | 104.00K | 30.00M | 4.11M | 2.71M | 281.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 0.00 | -607.00K |
| Other Financing Activities | 0.00 | -2.22M | 2.12M | 158.00K | -- |
| Cash from Financing | -109.00K | 27.57M | 6.04M | 2.60M | 4.44M |
| Foreign Exchange rate Adjustments | -1.00K | -1.00K | 0.00 | -1.00K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.57M | 21.51M | 183.00K | -1.73M | -25.00K |